Pages that link to "Q34239395"
Jump to navigation
Jump to search
The following pages link to Stage-related proliferative activity determines c-myb functional requirements during normal human hematopoiesis (Q34239395):
Displaying 27 items.
- Positive autoregulation of c-myb expression via Myb binding sites in the 5' flanking region of the human c-myb gene (Q24595119) (← links)
- Regulation of proliferation and cytokine expression of bone marrow fibroblasts: role of c-myb (Q24680464) (← links)
- Selective Inhibition of Leukemia Cell Proliferation by BCR-ABL Antisense Oligodeoxynucleotides (Q28285221) (← links)
- c-Myb binds MLL through menin in human leukemia cells and is an important driver of MLL-associated leukemogenesis (Q33604849) (← links)
- Myb targeted therapeutics for the treatment of human malignancies (Q33667372) (← links)
- Inhibition of T-cell proliferation by a MYB antisense oligomer is accompanied by selective down-regulation of DNA polymerase alpha expression (Q33728999) (← links)
- Oligonucleotide therapeutics for hematologic disorders (Q33916119) (← links)
- Autocrine stimulation by erythropoietin and autonomous growth of human erythroid leukemic cells in vitro (Q34197197) (← links)
- BCR/ABL: from molecular mechanisms of leukemia induction to treatment of chronic myelogenous leukemia (Q35022511) (← links)
- Antisense strategies to characterize the role of genes and oncogenes involved in myeloid differentiation (Q35241663) (← links)
- c-Myb interacts with the glucocorticoid receptor and regulates its level in pre-B-acute lymphoblastic leukemia cells (Q36113549) (← links)
- Myb: a transcriptional activator linking proliferation and differentiation in hematopoietic cells. (Q36354824) (← links)
- Leukemia treatment in severe combined immunodeficiency mice by antisense oligodeoxynucleotides targeting cooperating oncogenes (Q36365540) (← links)
- Transcriptional repression of c-Myb and GATA-2 is involved in the biologic effects of C/EBPalpha in p210BCR/ABL-expressing cells (Q36843757) (← links)
- Role of the KIT protooncogene in normal and malignant human hematopoiesis (Q36855012) (← links)
- Inhibition of leukemia cell proliferation by receptor-mediated uptake of c-myb antisense oligodeoxynucleotides (Q37133075) (← links)
- Regulation of BALB/c 3T3 fibroblast proliferation by B-myb is accompanied by selective activation of cdc2 and cyclin D1 expression (Q37279604) (← links)
- Normal and leukemic hematopoietic cells manifest differential sensitivity to inhibitory effects of c-myb antisense oligodeoxynucleotides: an in vitro study relevant to bone marrow purging (Q37439168) (← links)
- PU.1 supports proliferation of immature erythroid progenitors (Q38347809) (← links)
- Oligonucleotide N3'-->P5' phosphoramidates as antisense agents (Q39716115) (← links)
- Overexpression of the zinc finger protein MZF1 inhibits hematopoietic development from embryonic stem cells: correlation with negative regulation of CD34 and c-myb promoter activity (Q40017527) (← links)
- Transcriptional elongation of c-myb is regulated by NF-kappaB (p50/RelB). (Q41709141) (← links)
- Growth factor-dependent inhibition of normal hematopoiesis by N-ras antisense oligodeoxynucleotides (Q41962689) (← links)
- c-Myb function in fibroblasts (Q42834282) (← links)
- Functional significance of c-myb expression in normal and leukemic hematopoiesis (Q43412705) (← links)
- Potential therapeutic applications of antisense oligodeoxynucleotides in the treatment of chronic myelogenous leukemia. (Q53485328) (← links)
- Therapeutic Applications of Antisense DNA in the Treatment of Human Leukemiaa (Q67469361) (← links)